| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/25/2007 | CN2892127Y Respiratory tract disease therapeutic apparatus |
| 04/25/2007 | CN1953991A Altered fibronectin-binding protein of staphylococcus aureus |
| 04/25/2007 | CN1953783A Treatment of diseases |
| 04/25/2007 | CN1953768A Highly concentrated liquid formulations of anti-EGFR antibodies |
| 04/25/2007 | CN1953767A Regulatory T cells suppress autoimmunity |
| 04/25/2007 | CN1953766A Methods of treating skin disorders |
| 04/25/2007 | CN1952140A Cloning of Japanese blood fluke vaccine antigen gene and its expression and application |
| 04/25/2007 | CN1951967A Monoclonal antibody for resisting human osteogenesis induction factor and its preparation method and uses |
| 04/25/2007 | CN1951962A Polypeptide for preparing antineoplastic antibody and its uses |
| 04/25/2007 | CN1951502A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/25/2007 | CN1951499A A cell mediated immunity vaccine and preparation method thereof |
| 04/25/2007 | CN1951496A Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/25/2007 | CN1951495A Nano target medicine for magnetothermal therapy of malignant tumor |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1951374A A chicken Coccidiosis pill form vaccine and preparation method thereof |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312172C Use of tissue fibre proteinogen |
| 04/25/2007 | CN1312171C DNA vaccines encoding HIV accessory proteins |
| 04/25/2007 | CN1311871C DNA expression vectors and methods of use |
| 04/24/2007 | USRE39586 Secreted by the hybridoma cell line deposited in the Cell; Peripheral blood lymphocytes are activated in vitro with pokeweed mitogen and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies |
| 04/24/2007 | USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208579 IL4 receptor antagonists for horse, dog and cat |
| 04/24/2007 | US7208574 Host receptor for pathogenic bacteria |
| 04/24/2007 | US7208523 Slight toxicity and can be administered orally or intravenously to improve liver function |
| 04/24/2007 | US7208479 Peritoneal dialysis solution containing modified icodextrins |
| 04/24/2007 | US7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/24/2007 | US7208475 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/24/2007 | US7208470 Treating testicular cancer, ovarian cancer, prostate cancer with a biodrug protein; activin binding activity; hormone inhibitor |
| 04/24/2007 | US7208280 Controlling gene expression in tissue |
| 04/24/2007 | US7208267 Compositions and methods relating to breast specific genes and proteins |
| 04/24/2007 | US7208174 Liposome compositions |
| 04/24/2007 | US7208166 Use of botuline toxin to obtain a product to be used in articular pathologies, particularly coxarthrosis, epicondylitis and rotator muscle cap pathology |
| 04/24/2007 | US7208165 Human cytomegalovirus DNA sequences |
| 04/24/2007 | US7208164 Administering a vaccine contains an immunogenically effective amount of a live, avirulent strain of infectious bronchitis virus, in ovo of a fertile egg of a chicken |
| 04/24/2007 | US7208163 Method for producing temperature-sensitive morbillivirus |
| 04/24/2007 | US7208162 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| 04/24/2007 | US7208161 Chimeric viral particle for use as tool in the prevention and treatment of bacterial and viral disease in humans |
| 04/24/2007 | US7208157 Proteolysis targeting chimeric pharmaceutical |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | US7208155 Agent for treating allergic or hypersensitivity condition |
| 04/24/2007 | US7208153 Method for the improvement of neuronal regeneration |
| 04/24/2007 | US7208152 Antibodies for “Bonzo” chemokine receptor and therapeutic uses thereof |
| 04/24/2007 | US7208151 Antitumor agents; monoclonal antibodies |
| 04/24/2007 | US7208150 Non-toxic fraction isolated from the venom of Vipera xanthina, for therapy of pain |
| 04/24/2007 | US7208149 IL-16 antagonist peptides and DNA encoding the peptides |
| 04/24/2007 | US7208148 Chemically modified cytokines |
| 04/24/2007 | US7208146 Vaccine comprising at least two recombinant variable regions of immunoglobulin molecules derived from B-cell lymphoma cells, wherein cells express at least two different immunoglobulin molecules differing by one idiotype |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2114849C Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 04/24/2007 | CA2091346C Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/20/2007 | CA2625850A1 Methods and materials for producing a generic anti-amyloid immune response in mammals |
| 04/19/2007 | WO2007044731A2 Recombinant proteins from filoviruses and their use |
| 04/19/2007 | WO2007044695A2 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 04/19/2007 | WO2007044620A2 Optimal polyvalent vaccine for cancer |
| 04/19/2007 | WO2007044483A2 Attenuated vaccines for non-segmented negative sense rna viruses |
| 04/19/2007 | WO2007044406A2 Methods for stimulating an immune response using bacterial antigen delivery system |
| 04/19/2007 | WO2007044382A2 Proteins with improved solubility and methods for producing and using same |
| 04/19/2007 | WO2007044323A2 Fusion proteins for blood-brain barrier delivery |
| 04/19/2007 | WO2007044321A2 Latent procytotoxins and uses thereof |
| 04/19/2007 | WO2007043641A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 04/19/2007 | WO2007043635A1 Preventive/remedy for cancer |
| 04/19/2007 | WO2007042884A1 Vaccines and methods to treat canine influenza |
| 04/19/2007 | WO2007042827A2 Treatment and diagnosis of obligate intracellular pathogens |
| 04/19/2007 | WO2007042583A1 Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 04/19/2007 | WO2007042573A2 Compositions and methods for treating proliferative disorders |
| 04/19/2007 | WO2007042524A2 Treating diabetes using inhibitors of il-1 |
| 04/19/2007 | WO2007042326A2 Neisseria meningitidis antigens |
| 04/19/2007 | WO2007042289A2 Nanobodies™ and polypeptides against egfr and igf-ir |
| 04/19/2007 | WO2007042261A2 Compositions comprising cross-species-specific antibodies and uses thereof |
| 04/19/2007 | WO2007042169A2 Matrix metalloproteinase 11 vaccine |
| 04/19/2007 | WO2007041861A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 04/19/2007 | WO2007041842A1 An inflammatory mediator of cardiac adrenergic dysfunction |
| 04/19/2007 | WO2007041832A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | WO2007024535A3 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007024535A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007016285A3 M-csf specific monoclonal antibody and uses thereof |
| 04/19/2007 | WO2007014992A3 Antibodies directed against an ldl receptor |
| 04/19/2007 | WO2007013893A3 Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2007008904A3 Targeting poly-gamma-glutamic acid to treat staphylococcus epidermidis and related infections |
| 04/19/2007 | WO2007008093A3 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine |
| 04/19/2007 | WO2007007152A3 Anti-madcam antibodies to treat metastatic cancers and chloroma |
| 04/19/2007 | WO2006136460A8 New adjuvant |
| 04/19/2007 | WO2006134390A3 Method for diagnosing neurodegenerative disease |
| 04/19/2007 | WO2006134196A3 Use of melatonin as an adjuvant |
| 04/19/2007 | WO2006121848A3 Method for the isolation of spiroplasma in mammals |
| 04/19/2007 | WO2006116592A3 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 04/19/2007 | WO2006115413A3 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 04/19/2007 | WO2006091455A3 Molecular scaffolds for hiv-1 immunogens |
| 04/19/2007 | WO2006088972A3 Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism |
| 04/19/2007 | WO2006088925A3 Use of il17-f in diagnosis and therapy of airway inflammation |
| 04/19/2007 | WO2006087196A3 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9 |
| 04/19/2007 | WO2006086469A3 Antibodies to tgfbeta |
| 04/19/2007 | WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof |
| 04/19/2007 | WO2006076678A3 Prostate stem cell antigen vaccines and uses thereof |
| 04/19/2007 | WO2006071983A9 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 04/19/2007 | WO2006071784A3 Methods for inhibiting melanocyte stem cell loss |